You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fruquintinib

Showing 1 - 25 of 42
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TAS-102 in Combination With Regorafenib or Fruquintinib for

Not yet recruiting
  • TAS 102
  • +3 more
  • (no location specified)
Aug 7, 2023

Metastatic Colorectal Cancer Trial in Nanchang (Fruquintinib)

Recruiting
  • Metastatic Colorectal Cancer
  • Fruquintinib
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Nov 1, 2023

Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))

Recruiting
  • Hepatocellular Carcinoma
  • Fruquintinib
  • +2 more
  • Hangzhou, Zhejiang, China
    Guoliang Shao
Aug 1, 2023

Gastric Cancer Trial (Fruquintinib)

Not yet recruiting
  • Gastric Cancer
  • Fruquintinib
  • (no location specified)
Oct 17, 2023

Colorectal Cancer Metastatic Trial in Guangzhou (Fruquintinib)

Recruiting
  • Colorectal Cancer Metastatic
  • Fruquintinib
  • Guangzhou, Guangdong, China
    Colorectal Department,SunYat-sen University Cancer Center
Aug 28, 2023

Fruquintinib With PD-1 Inhibitors Versus TAS-102 With

Completed
  • Metastatic Colorectal Adenocarcinoma
  • Fruquintinib
  • +3 more
  • Changsha, Hunan, China
    Hunan Cancer hospital
Sep 2, 2023

Stomach Tumors Trial in Shanghai (Fruquintinib, Sintilimab)

Active, not recruiting
  • Stomach Neoplasms
  • Shanghai, China
    Renji Hospital
Apr 3, 2023

Rectal Cancer Trial in Chengdu (drug, radiation, procedure)

Recruiting
  • Rectal Cancer
  • Fruquintinib
  • +3 more
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Mar 8, 2023

Gastric Cancer Trial (Fruquintinib, Irinotecan)

Not yet recruiting
  • Gastric Cancer
  • (no location specified)
Dec 6, 2022

Colorectal Cancer Trial in Shanghai (serplulimab, Fruquintinib)

Not yet recruiting
  • Colorectal Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Jul 13, 2023

Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma Trial (fruquintinib, Envafolimab)

Not yet recruiting
  • Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma
  • (no location specified)
Jul 10, 2023

Colorectal Cancer, Microsatellite Stable Colorectal Carcinoma Trial in Shanghai (Vitamin E, Fruquintinib, Tislelizumab)

Not yet recruiting
  • Colorectal Cancer
  • Microsatellite Stable Colorectal Carcinoma
  • Vitamin E
  • +2 more
  • Shanghai, Shanghai, China
    270 Dongan Road, Fudan University Shanghai Cancer Center
Mar 5, 2023

Stomach Tumors Trial in Wuhan (Fruquintinib, Sintilimab)

Not yet recruiting
  • Stomach Neoplasms
  • Wuhan, Hubei, China
    Wuhan Union Hospital, China
Nov 22, 2022

Metastatic Colorectal Cancer Trial in ShangHai (Fruquintinib)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Fruquintinib
  • ShangHai, Shanghai, China
    Fudan University Cancer Hospital
Jul 3, 2022

Metastatic Colorectal Cancer Trial in Austin (Fruquintinib, Dabigatran Etexilate, Rosuvastatin)

Completed
  • Metastatic Colorectal Cancer
  • Fruquintinib
  • +2 more
  • Austin, Texas
    PPD Development
Oct 5, 2022

Metastatic Colorectal Cancer Trial in Shanghai (Fruquintinib, FOLFIRI, mFOLFOX6)

Not yet recruiting
  • Metastatic Colorectal Cancer
  • Fruquintinib
  • +2 more
  • Shanghai, Shanghai, China
    Department of Colorectal Surgery Fudan University Shanghai Caner
Nov 23, 2022

Colorectal Cancer Trial in Shanghai (HAIC, Fruquintinib, Tislelizumab)

Recruiting
  • Colorectal Cancer
  • HAIC
  • +5 more
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Aug 15, 2022

Colorectal Cancer Trial in Beijing, Dalian, Hohhot (Fruquintinib, HAIC)

Recruiting
  • Colorectal Cancer
  • Beijing, China
  • +2 more
Aug 19, 2022

Soft Tissue Sarcoma Trial in Shanghai (Fruquintinib)

Recruiting
  • Soft Tissue Sarcoma
  • Fruquintinib
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 1, 2022

Advanced Colorectal Carcinoma, Liver Metastasis Colon Cancer Trial in Beijing (Fruquintinib, Hepatic Arterial Infusion

Recruiting
  • Advanced Colorectal Carcinoma
  • Liver Metastasis Colon Cancer
  • Fruquintinib
  • Hepatic Arterial Infusion Chemotherapy
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Jun 1, 2022

Colorectal Tumors Trial in Xiamen (hypofractionation Radiotherapy, sintilimab, GM-CSF)

Recruiting
  • Colorectal Neoplasms
  • hypofractionation Radiotherapy
  • +3 more
  • Xiamen, Fujian, China
    The First Affiliated Hospital of Xiamen University
Mar 28, 2022

Advanced Colorectal Carcinoma Trial in Shanghai (Fruquintinib and raltitrexed, Fruquintinib)

Recruiting
  • Advanced Colorectal Carcinoma
  • Fruquintinib and raltitrexed
  • Fruquintinib
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Oct 18, 2021

Advanced Pancreatic Carcinoma Trial in Shanghai (Fruquintinib)

Not yet recruiting
  • Advanced Pancreatic Carcinoma
  • Fruquintinib
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Feb 16, 2022

Colo-rectal Cancer Trial in Shanghai (Fruquintinib)

Recruiting
  • Colo-rectal Cancer
  • Fruquintinib
  • Shanghai, Shanghai, China
    Zhongshan Hospital Affiliated to Fudan University
Nov 1, 2021

Advanced Solid Tumors Trial in China, Korea, Republic of (Tislelizumab, Fruquintinib)

Recruiting
  • Advanced Solid Tumors
  • Fuzhou, Fujian, China
  • +13 more
Jun 29, 2022